RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Bill & Melinda Gates Foundation
B

Bill & Melinda Gates Foundation portfolio

Bill & Melinda Gates Foundation has 18 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Foundation.
Portfolio on Recent Funding: 18.
Deals, last 12 months: 1.
Capital in their rounds: $248.83M.
Latest deal: Addition Therapeutics · Dec 17, 2025.
About this page

It is a foundation based in Seattle, US, founded in 2000. Its most recent investment on record is Addition Therapeutics's $100M Series A round in December 2025, alongside OUP, Abingworth, SR One and 2 others. By category, its portfolio leans toward Health and bio (13) and Consumer and social (2). It has co-invested with Abingworth, SR One and OUP.

About Bill & Melinda Gates Foundation

Firm type: Foundation.
Headquarters: Seattle, US.
Founded: 2000.
Stages: Pre-Seed, Seed, Series A, Series B, Series C, Growth.
Sectors: AgTech, AI & Machine Learning, Digital Health, EdTech, Fintech, FoodTech, Healthtech, Impact & Social Good.

What Bill & Melinda Gates Foundation invests in

Bill & Melinda Gates Foundation recent investments

CompanyRoundDateAlongside
AAddition TherapeuticsSeries A · $100MOUP, Abingworth (lead), SR One (lead) +2
NNilo TherapeuticsSeries A · $101MDCVC Bio (lead), Lux Capital (lead), Alexandria Venture Investments +1
BBactolifeSeries A · $32.83MNovo Holdings, European Equity Partners, Athos Capital (lead)
KKaleidofinSeries B+ · $15MMichael & Susan Dell Foundation (lead)

How Bill & Melinda Gates Foundation invests

StageDealsCapital in rounds
Series A 3 75%$233.83M
Series B+ 1 25%$15M
YearDealsCapital in rounds
2022 1 25%$15M
2023 1 25%$32.83M
2025 2 50%$201M

Bill & Melinda Gates Foundation portfolio companies

CompanyRound with Bill & Melinda Gates FoundationTotal raisedLatest raise
AAddition Therapeutics
Health and bio
Series A · $100M$100MDec 17, 2025
Series A
NNilo Therapeutics
Health and bio
Series A · $101M$101MOct 8, 2025
Series A
BBactolife
Health and bio
Series A · $32.83M$76.16MJan 6, 2026
Series B+
KKaleidofin
Fintech
Series B+ · $15M$32.87MSep 20, 2024
Series B+
TTriGemX Bio
Health and bio
backer$94MOct 1, 2026
round
PPuna Bio
Health and bio
backer$24MApr 1, 2025
Series A
SSwipeRX
Health and bio
backerundisclosed—
SStellapps
Commerce and retail
backer$26MFeb 3, 2026
Series B+
EEnergaia
Consumer and social
backerundisclosed—
OOsmo
Health and bio
backer$60MFeb 4, 2026
Series B+
CChemify
Robotics and hardware
backer$50MOct 21, 2025
Series B+
EEnsoma
Health and bio
backer$50MMay 16, 2023
Series B+
BBiomEdit
Health and bio
backerundisclosedFeb 16, 2026
Series B+
CConverge Bio
Foundation models and research
backer$30.5MJan 13, 2026
Series A
FFreya Biosciences
Health and bio
backer$38MNov 19, 2024
Series A
SSurf Bio
Health and bio
backer$16MApr 12, 2022
Seed
BBloomBoard
Developer tools and cloud
backer$12.2MFeb 3, 2026
Series B+
SSibel Health
Health and bio
backer$63MOct 14, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 4 rounds on Recent Funding that name Bill & Melinda Gates Foundation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Bill & Melinda Gates Foundation, which is a subset of its real portfolio. API: /api/v1/investors/bill-melinda-gates-foundation (get a free API key). More: the most active VC firms and new venture capital funds.